Symbols / IINN $0.41 -14.78% Inspira Technologies Oxy B.H.N. Ltd.
IINN Chart
About
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 17.92M |
| Enterprise Value | 18.34M | Income | -13.22M | Sales | 289.00K |
| Book/sh | 0.07 | Cash/sh | 0.07 | Dividend Yield | — |
| Payout | 0.00% | Employees | 34 | IPO | — |
| P/E | — | Forward P/E | -0.59 | PEG | — |
| P/S | 61.99 | P/B | 6.32 | P/C | — |
| EV/EBITDA | -1.36 | EV/Sales | 63.47 | Quick Ratio | 1.12 |
| Current Ratio | 1.56 | Debt/Eq | 20.66 | LT Debt/Eq | — |
| EPS (ttm) | -0.45 | EPS next Y | -0.70 | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -126.98% |
| ROE | -3.98% | ROIC | — | Gross Margin | 0.69% |
| Oper. Margin | -47.14% | Profit Margin | 0.00% | Shs Outstand | 43.58M |
| Shs Float | 36.51M | Short Float | 1.03% | Short Ratio | 2.83 |
| Short Interest | — | 52W High | 1.65 | 52W Low | 0.34 |
| Beta | 2.33 | Avg Volume | 617.73K | Volume | 919.19K |
| Target Price | $5.00 | Recom | None | Prev Close | $0.48 |
| Price | $0.41 | Change | -14.78% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$5.00
Mean price target
2. Current target
$0.41
Latest analyst target
3. DCF / Fair value
$-2.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.41
Low
$5.00
High
$5.00
Mean
$5.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-06-02 | init | Litchfield Hills | — → Buy | $2 |
- Inspira turns AME tech toward a $72B quantum computing bottleneck - Stock Titan Mon, 06 Apr 2026 13
- Inspira buys 3D electronics printing platform in $12.5M deal - Stock Titan Mon, 06 Apr 2026 12
- Inspira Technologies Repositions as QTREX With Quantum Connectivity Push - TipRanks Mon, 06 Apr 2026 13
- Inspira Technologies Announces Termination of Sales and Equity Purchase Agreements - Quiver Quantitative ue, 31 Mar 2026 12
- Nano Dimension announces the sale of AME and Fabrica product lines - marketscreener.com Mon, 06 Apr 2026 12
- IINN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI Wed, 01 Apr 2026 10
- Inspira Technologies Closes $12.5 Million Acquisition of Nano Dimension’s AME Platform - TipRanks Mon, 06 Apr 2026 13
- Inspira Technologies (NASDAQ: IINN) acquires Nano Dimension AME platform in $12.5M deal - Stock Titan Mon, 06 Apr 2026 12
- Inspira Technologies (IINN) pivots to quantum connectivity, plans QTREX rebrand - Stock Titan Mon, 06 Apr 2026 13
- Inspira exits two equity funding deals before its next strategic phase - Stock Titan ue, 31 Mar 2026 12
- Why a $49.5M life-support tech deal is now aligned with 2026 milestones - Stock Titan ue, 23 Dec 2025 08
- After first patient use, Inspira lines up $49.5M in hospital orders - Stock Titan hu, 26 Mar 2026 07
- Inspira Technologies (IINN) terminates ATM and SEPA equity facilities for next strategic phase - Stock Titan ue, 31 Mar 2026 12
- Tal Parnes details Inspira Technologies (IINN) shares, options and RSUs in Form 3 - Stock Titan hu, 19 Mar 2026 07
- Inspira Technologies (IINN) shifts medical business to new unit - Stock Titan hu, 26 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.29
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.29
|
0.00
|
0.00
|
0.00
|
| Cost Of Revenue |
|
0.29
|
0.00
|
0.00
|
—
|
| Reconciled Cost Of Revenue |
|
0.25
|
0.00
-100.00%
|
0.00
|
—
|
| Gross Profit |
|
0.00
|
0.00
|
0.00
|
—
|
| Operating Expense |
|
13.62
+20.93%
|
11.27
-7.14%
|
12.13
-18.53%
|
14.89
|
| Research And Development |
|
7.50
+18.55%
|
6.32
-13.62%
|
7.32
-10.55%
|
8.18
|
| Selling General And Administration |
|
5.88
+25.52%
|
4.69
+2.67%
|
4.57
-29.74%
|
6.50
|
| Selling And Marketing Expense |
|
0.09
+82.35%
|
0.05
-16.39%
|
0.06
+281.25%
|
0.02
|
| General And Administrative Expense |
|
5.79
+24.89%
|
4.64
+2.93%
|
4.50
-30.50%
|
6.48
|
| Salaries And Wages |
|
3.37
+47.92%
|
2.28
+12.88%
|
2.02
-45.78%
|
3.72
|
| Other Gand A |
|
2.24
+3.70%
|
2.16
-1.10%
|
2.19
-0.68%
|
2.20
|
| Other Operating Expenses |
|
0.13
-6.43%
|
0.14
+5.26%
|
0.13
+22.02%
|
0.11
|
| Total Expenses |
|
13.91
+23.48%
|
11.27
-7.14%
|
12.13
-18.53%
|
14.89
|
| Operating Income |
|
-13.62
-20.91%
|
-11.27
+7.14%
|
-12.13
+18.53%
|
-14.89
|
| Total Operating Income As Reported |
|
-13.62
-20.91%
|
-11.27
+7.14%
|
-12.13
+18.53%
|
-14.89
|
| EBITDA |
|
-13.47
-21.42%
|
-11.10
+7.67%
|
-12.02
+18.74%
|
-14.79
|
| Normalized EBITDA |
|
-13.57
-21.49%
|
-11.17
+8.80%
|
-12.25
+14.08%
|
-14.26
|
| Reconciled Depreciation |
|
0.15
-12.28%
|
0.17
+54.05%
|
0.11
+105.56%
|
0.05
|
| EBIT |
|
-13.62
-20.91%
|
-11.27
+7.14%
|
-12.13
+18.53%
|
-14.89
|
| Total Unusual Items |
|
0.10
+31.17%
|
0.08
-66.95%
|
0.23
+143.96%
|
-0.53
|
| Total Unusual Items Excluding Goodwill |
|
0.10
+31.17%
|
0.08
-66.95%
|
0.23
+143.96%
|
-0.53
|
| Net Income |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Pretax Income |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Net Non Operating Interest Income Expense |
|
0.30
+120.44%
|
0.14
-77.69%
|
0.61
+37.36%
|
0.45
|
| Interest Expense Non Operating |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Net Interest Income |
|
0.30
+120.44%
|
0.14
-77.69%
|
0.61
+37.36%
|
0.45
|
| Interest Expense |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Interest Income Non Operating |
|
0.06
-62.79%
|
0.17
-45.91%
|
0.32
+65.63%
|
0.19
|
| Interest Income |
|
0.06
-62.79%
|
0.17
-45.91%
|
0.32
+65.63%
|
0.19
|
| Other Income Expense |
|
0.10
+31.17%
|
0.08
-66.95%
|
0.23
+143.96%
|
-0.53
|
| Gain On Sale Of Security |
|
0.10
+31.17%
|
0.08
-66.95%
|
0.23
+143.96%
|
-0.53
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Net Income From Continuing Operation Net Minority Interest |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Net Income From Continuing And Discontinued Operation |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Net Income Continuous Operations |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Normalized Income |
|
-13.32
-19.69%
|
-11.13
+3.38%
|
-11.52
+20.26%
|
-14.45
|
| Net Income Common Stockholders |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Diluted EPS |
|
—
|
—
|
-0.93
-2.65%
|
-0.91
|
| Basic EPS |
|
—
|
—
|
-0.93
-2.65%
|
-0.91
|
| Basic Average Shares |
|
—
|
—
|
12.10
+6.67%
|
11.34
|
| Diluted Average Shares |
|
—
|
—
|
12.10
+6.67%
|
11.34
|
| Diluted NI Availto Com Stockholders |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Depreciation Amortization Depletion Income Statement |
|
0.12
-1.71%
|
0.12
+1.74%
|
0.12
+10.58%
|
0.10
|
| Depreciation And Amortization In Income Statement |
|
0.12
-1.71%
|
0.12
+1.74%
|
0.12
+10.58%
|
0.10
|
| Depreciation Income Statement |
|
0.12
-1.71%
|
0.12
+1.74%
|
0.12
+10.58%
|
0.10
|
| Insurance And Claims |
|
0.18
-9.18%
|
0.20
-34.67%
|
0.30
-46.14%
|
0.56
|
| Total Other Finance Cost |
|
-0.24
-780.00%
|
0.04
+111.82%
|
-0.30
-16.08%
|
-0.26
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
9.31
|
| Current Assets |
|
7.79
|
| Cash Cash Equivalents And Short Term Investments |
|
7.36
|
| Cash And Cash Equivalents |
|
5.04
|
| Other Short Term Investments |
|
2.32
|
| Inventory |
|
0.00
|
| Raw Materials |
|
0.00
|
| Work In Process |
|
0.00
|
| Finished Goods |
|
0.00
|
| Prepaid Assets |
|
0.18
|
| Restricted Cash |
|
0.09
|
| Other Current Assets |
|
0.17
|
| Total Non Current Assets |
|
1.52
|
| Net PPE |
|
1.52
|
| Gross PPE |
|
1.72
|
| Accumulated Depreciation |
|
-0.20
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.29
|
| Other Properties |
|
1.39
|
| Leases |
|
0.04
|
| Total Liabilities Net Minority Interest |
|
3.57
|
| Current Liabilities |
|
2.98
|
| Payables And Accrued Expenses |
|
1.22
|
| Payables |
|
0.57
|
| Accounts Payable |
|
0.20
|
| Other Payable |
|
0.02
|
| Current Accrued Expenses |
|
0.66
|
| Current Debt And Capital Lease Obligation |
|
0.29
|
| Current Capital Lease Obligation |
|
0.29
|
| Other Current Liabilities |
|
1.47
|
| Total Non Current Liabilities Net Minority Interest |
|
0.59
|
| Long Term Debt And Capital Lease Obligation |
|
0.59
|
| Long Term Debt |
|
—
|
| Long Term Capital Lease Obligation |
|
0.59
|
| Stockholders Equity |
|
5.74
|
| Common Stock Equity |
|
5.74
|
| Capital Stock |
|
61.26
|
| Common Stock |
|
61.26
|
| Share Issued |
|
15.65
|
| Ordinary Shares Number |
|
15.65
|
| Treasury Shares Number |
|
0.00
|
| Retained Earnings |
|
-55.52
|
| Gains Losses Not Affecting Retained Earnings |
|
—
|
| Total Equity Gross Minority Interest |
|
5.74
|
| Total Capitalization |
|
5.74
|
| Working Capital |
|
4.81
|
| Invested Capital |
|
5.74
|
| Total Debt |
|
0.88
|
| Capital Lease Obligations |
|
0.88
|
| Net Tangible Assets |
|
5.74
|
| Tangible Book Value |
|
5.74
|
| Dueto Related Parties Current |
|
0.35
|
| Foreign Currency Translation Adjustments |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.86
-5.20%
|
-9.37
+3.27%
|
-9.69
-5.23%
|
-9.21
|
| Cash Flow From Continuing Operating Activities |
|
-9.86
-5.20%
|
-9.37
+3.27%
|
-9.69
-5.23%
|
-9.21
|
| Net Income From Continuing Operations |
|
-13.22
-19.61%
|
-11.05
+2.06%
|
-11.29
+24.64%
|
-14.98
|
| Depreciation Amortization Depletion |
|
0.15
-12.28%
|
0.17
+54.05%
|
0.11
+105.56%
|
0.05
|
| Depreciation |
|
0.15
-12.28%
|
0.17
+54.05%
|
0.11
+105.56%
|
0.05
|
| Depreciation And Amortization |
|
0.15
-12.28%
|
0.17
+54.05%
|
0.11
+105.56%
|
0.05
|
| Other Non Cash Items |
|
0.59
+1302.38%
|
0.04
-78.79%
|
0.20
+488.24%
|
-0.05
|
| Stock Based Compensation |
|
3.58
+88.95%
|
1.89
+27.32%
|
1.49
-69.54%
|
4.88
|
| Operating Gains Losses |
|
-0.02
+68.00%
|
-0.05
-176.92%
|
0.07
-85.16%
|
0.44
|
| Unrealized Gain Loss On Investment Securities |
|
-0.72
-1631.91%
|
0.05
+115.36%
|
-0.31
-183.33%
|
-0.11
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.03
+54.55%
|
-0.06
-184.62%
|
0.07
-85.16%
|
0.44
|
| Change In Working Capital |
|
-0.22
+48.23%
|
-0.42
-1131.71%
|
0.04
-92.61%
|
0.56
|
| Change In Inventory |
|
-0.29
+34.46%
|
-0.44
|
0.00
|
0.00
|
| Change In Prepaid Assets |
|
—
|
—
|
-0.01
+86.27%
|
-0.05
|
| Change In Payables And Accrued Expense |
|
-0.10
-241.89%
|
0.07
+151.39%
|
-0.14
-125.95%
|
0.56
|
| Change In Payable |
|
-0.10
-241.89%
|
0.07
+151.39%
|
-0.14
-125.95%
|
0.56
|
| Change In Account Payable |
|
-0.05
-6.82%
|
-0.04
-195.65%
|
0.05
-22.03%
|
0.06
|
| Change In Other Current Assets |
|
0.18
+433.96%
|
-0.05
-128.65%
|
0.18
|
0.00
|
| Investing Cash Flow |
|
0.56
-62.03%
|
1.49
-67.61%
|
4.59
+162.22%
|
-7.38
|
| Cash Flow From Continuing Investing Activities |
|
0.56
-62.03%
|
1.49
-67.61%
|
4.59
+162.22%
|
-7.38
|
| Net PPE Purchase And Sale |
|
-0.10
+37.20%
|
-0.16
+20.39%
|
-0.21
+21.67%
|
-0.26
|
| Purchase Of PPE |
|
-0.10
+37.20%
|
-0.16
+20.39%
|
-0.21
+21.67%
|
-0.26
|
| Capital Expenditure |
|
-0.10
+37.20%
|
-0.16
+20.39%
|
-0.21
+21.67%
|
-0.26
|
| Net Investment Purchase And Sale |
|
—
|
—
|
4.80
+167.42%
|
-7.12
|
| Purchase Of Investment |
|
—
|
—
|
0.00
+100.00%
|
-7.12
|
| Sale Of Investment |
|
—
|
—
|
4.80
|
0.00
|
| Net Other Investing Changes |
|
0.67
-59.56%
|
1.65
-65.58%
|
4.80
+167.42%
|
-7.12
|
| Financing Cash Flow |
|
7.33
-7.28%
|
7.90
+128.84%
|
3.45
|
0.00
|
| Cash Flow From Continuing Financing Activities |
|
7.33
-7.28%
|
7.90
+128.84%
|
3.45
|
0.00
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-0.40
|
| Issuance Of Debt |
|
—
|
—
|
0.00
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
-0.40
|
| Long Term Debt Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
-0.40
|
| Net Long Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-0.40
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Common Stock Issuance |
|
6.41
-18.90%
|
7.90
+128.93%
|
3.45
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.92
+22950.00%
|
0.00
+33.33%
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
-0.45
|
—
|
| Changes In Cash |
|
-1.97
-12406.25%
|
0.02
+100.97%
|
-1.64
+90.09%
|
-16.59
|
| Effect Of Exchange Rate Changes |
|
0.03
-54.55%
|
0.06
+184.62%
|
-0.07
+85.16%
|
-0.44
|
| Beginning Cash Position |
|
5.20
+1.38%
|
5.13
-24.99%
|
6.84
-71.35%
|
23.87
|
| End Cash Position |
|
3.26
-37.38%
|
5.20
+1.38%
|
5.13
-24.99%
|
6.84
|
| Free Cash Flow |
|
-9.96
-4.47%
|
-9.54
+3.63%
|
-9.90
-4.49%
|
-9.47
|
| Interest Paid Supplemental Data |
|
0.07
-9.72%
|
0.07
-22.58%
|
0.09
-12.26%
|
0.11
|
| Common Stock Issuance |
|
6.41
-18.90%
|
7.90
+128.93%
|
3.45
|
0.00
|
| Issuance Of Capital Stock |
|
6.41
-18.90%
|
7.90
+128.93%
|
3.45
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|